This category is for adults with type 2 diabetes, obesity, or overweight with weight-related conditions under medical supervision
Szekanecz Z, Buch MH, Charles-Schoeman C, Galloway J, Karpouzas GA, Kristensen LE, Ytterberg SR, Hamar A, Fleischmann R
Mina Tadrous, a pharmaceutical policy expert at the University of Toronto, said a generic semaglutide medication is unlikely to be approved until late spring or early summer
A: The main benefit of Wegovy is its ability to assist adults with obesity or weight-related medical conditions in managing their weight
Florida Surgery and Weight Loss Center provides telehealth consultations and in-office care for patients throughout Florida
In some cases, adjusting the way the medication is taken or making dietary changes can help reduce the symptoms